Hidden Markov Model for Automatic Transcription of MIDI Signals

This paper describes a Hidden Markov Model (HMM)-based method of automatic transcription of MIDI (Musical Instrument Digital Interface) signals of performed music. The problem is formulated as recognition of a given sequence of fluctuating note durations to find the most likely intended note sequence utilizing the modern continuous speech recognition technique. Combining a stochastic model of deviating note durations and a stochastic grammar representing possible sequences of notes, the maximum likelihood estimate of the note sequence is searched in terms of Viterbi algorithm. The same principle is successfully applied to a joint problem of bar line allocation, time measure recognition, and tempo estimation. Finally, durations of consecutive n notes are combined to form a "rhythm vector" representing tempo-free relative durations of the notes and treated in the same framework. Significant improvements compared with conventional "quantization" techniques are shown

Plasma substance p levels in patients with persistent cough.

Background: Substance P (SP) is involved in the pathogenesis of cough in animal models. However, few studies in humans have been reported and the roles of SP in clinical cough remain obscure. Objectives: To clarify the relevance of plasma levels of SP in patients with persistent cough. Methods: We studied 82 patients with cough persisting for at least 3 weeks and 15 healthy controls. Patients were classified as having asthmatic cough (cough-variant asthma and cough-predominant asthma; n = 61) or nonasthmatic cough (n = 21; postinfectious cough, n = 6; gastroesophageal reflux disease, n = 5; idiopathic cough, n = 5, and others, n = 5). Correlations were evaluated between plasma SP levels as measured with ELISA and methacholine airway hyperresponsiveness (airway sensitivity and airway reactivity), capsaicin cough sensitivity, sputum eosinophil and neutrophil counts, and pulmonary function. Results: Plasma SP levels were significantly elevated in patients with both asthmatic and nonasthmatic cough compared with controls [31.1 pg/ml (range 18.0-52.2) and 30.0 pg/ml (range 15.1-50.3) vs. 15.4 pg/ml (range 11.3-23.7); p = 0.003 and p = 0.038, respectively] but did not differ between the two patient groups (p = 0.90). Plasma SP levels correlated with airway sensitivity (threshold dose of methacholine) in the patients with asthmatic cough (r = -0.37, p = 0.005) but not with airway reactivity, cough sensitivity, FEV(1) values, or sputum eosinophil and neutrophil counts in either group. Conclusions: Increased levels of SP in plasma are associated with persistent cough in humans and might be related to airway sensitivity in asthmatic cough

Sputum YKL-40 Levels and Pathophysiology of Asthma and Chronic Obstructive Pulmonary Disease.

Background: Recent evidence suggests that YKL-40, also called chitinase-3-like-1 protein, is involved in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD). Details of sputum YKL-40 in asthma and COPD, however, remain unknown. Objectives: To clarify associations of sputum YKL-40 levels with clinical indices in asthma and COPD. Methods: Thirty-nine patients with asthma, 14 age-matched never-smokers as controls, 45 patients with COPD, and 7 age-matched smokers as controls were recuited for this study. Sputum YKL-40 levels were measured and YKL-40 expression in sputum cells was evaluated by immunocytochemistry. Results: Sputum YKL-40 levels were higher in patients with COPD (346 ± 325 ng/ml) than in their smoker controls (125 ± 122 ng/ml; p < 0.05), but were not significantly different between patients with asthma (117 ± 170 ng/ml) and their controls (94 ± 44 ng/ml; p = 0.15). In patients with asthma only, sputum YKL-40 levels were positively correlated with disease severity (r = 0.34, p = 0.034) and negatively correlated with pre- and postbronchodilator %FEV(1) (r = -0.47 and -0.42, respectively; p < 0.01) and forced mid-expiratory flow (r = -0.48 and -0.46, respectively, p < 0.01). Sputum YKL-40 levels were positively correlated with sputum neutrophil counts in asthma (r = 0.55, p < 0.001) and with neutrophil and macrophage counts in COPD (r = 0.45 and 0.65, respectively, p < 0.01). YKL-40 was expressed in the cytoplasm of sputum neutrophils and macrophages in all groups. Conclusions: Elevated sputum YKL-40 reflects airflow obstruction in asthma whereas the roles of YKL-40 in the proximal airways in COPD remain to be elucidated

NinjaSat: 6U CubeSat Observatory for Bright X-Ray Sources

NinjaSat is a 6U CubeSat observatory designed for long-term monitoring of bright X-ray sources, such as binary systems between normal stars and black holes or neutron stars. NinjaSat is the first Japanese CubeSat dedicated to astronomical observation, and it is also a mission to demonstrate that even a small satellite, which can be developed quickly and inexpensively, unlike large satellites, can perform excellent scientific observations. NinjaSat realizes the world’s highest X-ray sensitivity in CubeSat missions by using gas X-ray detectors filling the entire space allocated for science payloads. The fabrication of the flight model payloads began in 2021, and testing at the payload component level was completed in August 2022; as of April 2023, the payloads were integrated into the Nano Avionics 6U bus (M6P) in Lithuania. After four months of testing, the payload will be stored in the Exolaunch deployer in August and launched by the SpaceX Transporter-9 mission in October 2023. This paper will describe the scientific objectives, satellite structure, payloads, and operations of NinjaSat

Development of Gas Multiplier Counters (GMCs) Onboard the 6U CubeSat X-Ray Observatory NinjaSat

We report the development of Gas Multiplier Counters (GMCs) onboard the 6U CubeSat X-ray observatory NinjaSat, scheduled to be launched in October 2023. GMC is a 1U-size non-imaging gas X-ray detector sensitive to 2–50 keV X-rays, and two identical GMCs are mounted on NinjaSat. GMC consists of a gas cell filled with a xenon/argon/dimethyl ether (75%/24%/1%) gas mixture with a pressure of 1.2 atm at 0◦C, a high voltage supply and analog signal processing board, a digital signal processing board, an X-ray collimator of a 2.1◦ field of view, and an iron-55 calibration source. The most significant feature of the GMC is its large effective area of 32 cm2 at 6 keV, which is more than two orders of magnitude larger than the X-ray detectors onboard previously launched CubeSats. We have achieved this at a low cost and in a short development time by employing a gas detector that can easily increase its effective area and using a space-proven gas electron multiplier. GMC was characterized with X-rays from an X-ray generator in a laboratory and monochromatic X-rays on the BL-14A beamline at the KEK synchrotron radiation facility. In this paper, we present the design of GMC and the preliminary results of the detector calibration

Development of Radiation Belt Monitors for the 6U CubeSat X-Ray Observatory NinjaSat

NinjaSat is a 6U CubeSat-sized X-ray observatory to be launched into the low Earth orbit at an altitude of 550 km, and is scheduled for launch this October. NinjaSat is equipped with two 1U-sized gas X-ray detectors (GMC) and is expected to operate mainly for astronomical observations of bright X-ray objects in the sky, such as neutron stars and black holes. Since high voltages are applied to the gas cells of GMC, two radiation belt monitors (RBM) will also be installed to protect GMC from electrical discharges potentially caused by excessively high rate of charged particles. NinjaSat RBM will play a fail-safe function in the voltage suppression operation of GMC in the auroral zone and South Atlantic Anomaly, and also protect GMC from charged particles such as protons and electrons that arrive unexpectedly due to solar flares or other low-Earth orbit radiation events. RBM uses a 9 mm x 9 mm Si-PIN photodiode as a charged particle sensor. By taking advantage of the difference in sensor response to protons and electrons, the sensor is designed to simultaneously count charged particle rates at multiple energy thresholds so that GMC protection function will operate even if either the proton or electron rate increases. RBM can count up to about 10 kcps with almost no loss of counts, and proton beam tests have confirmed that the response performance is sufficient to protect GMC against excessively high charged particle rates above 10 Mcps without choking the circuitry. The flight models of the RBM have passed the thermal vacuum and vibration tests last year. The developed RBM occupies only about 6% of the 1U CubeSat size in volume and weighs only 70g. In addition, since the RBM uses inexpensive, commercially available sensors, it could be installed on small satellites other than NinjaSat with relatively small development resources

A Multicenter Phase II Study of Adjuvant Chemotherapy With Oral Fluoropyrimidine S-1 for Non–Small-Cell Lung Cancer: High Completion and Survival Rates

Background: Oral adjuvant chemotherapy without hospitalization might reduce the physiological and psychological burden on patients if effectiveness could be guaranteed. We conducted a multicenter feasibility study using S-1, an oral derivative of 5-fluorouracil, as postoperative adjuvant chemotherapy in patients with curatively resected pathologically stage IB-IIIA non-small-cell lung cancer. Patients and Methods: Adjuvant chemotherapy comprised 8 courses (4-week administration, 2-week withdrawal) of S-1 at 80-120 mg per day. Fifty-one patients from 7 institutions were enrolled in this pilot study, from June 2005 to March 2007. The primary end point was the completion rate of scheduled adjuvant chemotherapy. Secondary end points were the incidence and grade of adverse reactions. Results: Fifty patients were eligible. The completion rate for the planned 8 courses of S-1 administration was 72.0% (36 patients). Total percentage administration amount was 71.1%. Grade 3 adverse reactions such as neutropenia (4.0%), anorexia (4.0%), thrombopenia (2.0%), anemia (2.0%), elevated total bilirubin (2.0%), hypokalemia (2.0%), nausea (2.0%), and diarrhea (2.0%) were observed, but no grade 4 adverse effects were encountered. Overall and relapse-free survival rates at 3 years were 87.7% and 69.4%, respectively. Conclusions: Postoperative 1-year administration of S-1 seems feasible as oral adjuvant chemotherapy for lung cancer. The oral formulation and low incidence of adverse reactions permit treatment on an outpatient basis. The present study would be reasonable to follow up with a properly powered phase III trial

喘息における末梢気道機能と健康関連QOL・呼吸困難・疾患コントールとの関係

京都大学0048新制・課程博士博士(医学)甲第15208号医博第3408号新制||医||979(附属図書館)27686京都大学大学院医学研究科医学専攻(主査)教授 伊達 洋至, 教授 福原 俊一, 教授 三森 経世学位規則第4条第1項該当Doctor of Medical ScienceKyoto UniversityDA

Association of alveolar nitric oxide levels with pulmonary function and its reversibility in stable asthma.

Background: Inflammation of peripheral airways is implicated in the pathophysiology of severe asthma. However, contributions of peripheral airway inflammation to airway caliber/function in patients with stable asthma, including those with mild to moderate disease, remain to be confirmed. Objectives: To determine whether peripheral airway inflammation affects airway function in patients with asthma. Methods: In 70 patients with mild to severe asthma, alveolar nitric oxide [CANO(TMAD)] levels were examined as a noninvasive biomarker of peripheral airway/alveolar inflammation. CANO(TMAD) and maximal nitric oxide (NO) flux in the airway compartment, J’awNO, were estimated with a model that incorporated trumpet-shaped airways and axial diffusion using exhaled NO output at different flow rates. Measures of pulmonary function were then assessed by spirometry and an impulse oscillometry system, and their bronchodilator reversibility was examined. Results: CANO(TMAD) levels were not correlated with pre- or postbronchodilator spirometric values, but were significantly associated with prebronchodilator reactance at low frequency (Xrs5) (rho = –0.31, p = 0.011), integrated area of low-frequency Xrs (AX) (rho = 0.35, p = 0.003) and negative frequency dependence of resistance (Rrs5-Rrs20) (rho = 0.35, p = 0.004). Furthermore, CANO(TMAD) levels were associated with bronchodilator reversibility of FEV[1], FEF[25–75%], Xrs5 and AX (rho = 0.35, 0.31, –0.24 and –0.31, respectively; p ≤ 0.05 for all). No variables were related to J’awNO.Conclusions: Elevated CANO(TMAD), but not J’awNO, partly reflects reversible airway obstruction originating in the peripheral airway. These findings indicate the involvement of peripheral airway inflammation in physiological abnormalities in asthma

Centrilobular Opacities in the Asthmatic Lung Successfully Treated with Inhaled Ciclesonide and Tiotropium: With Assessment of Alveolar Nitric Oxide Levels

Background: Despite the fact that bronchioles are involved in asthma, there have been limited asthmatic cases showing marked centrilobular opacities on computed tomography (CT) chest scans. Systemic corticosteroids have been administered in such cases, but the efficacy of extra-fine particle inhaled corticosteroids has not been assessed. Case Summary: A previously healthy 64-year-old man presented with a four-month history of productive cough and progressive dyspnea despite a combination therapy with inhaled salmeterol (50 μg bid) and fluticasone (500 μg bid), sustained-release theophylline, and pranlukast because of suspicion of asthma. Physical examination revealed wheezing at the end of forced expiration. High resolution CT chest scan showed diffuse centrilobular opacities, bronchiectatic changes, and bronchial wall thickening. Transbronchial lung biopsy, bronchoalveolar lavage fluid, and transbronchial biopsy all showed predominant eosinophil infiltrates, suggesting that eosinophilic inflammation across the entire airway tree caused the abnormal CT findings. Alveolar fraction of exhaled nitric oxide level, a non-invasive marker of eosinophilic peripheral airway inflammation, was also elevated. Because he refused systemic corticosteroids, inhaled ciclesonide (400 μg bid) and inhaled tiotropium were added on to his current medication under careful observation. His symptoms, pulmonary function and CT findings promptly improved, and he had fully recovered at follow-up. Discussion: Extra-fine particle inhaled corticosteroids could be an alternative approach in centrilobular opacities caused by eosinophilic peripheral airway inflammation